I am suffering from a bad case of disease envy.
Cancer is suddenly everywhere this spring – a segment on 60 Minutes, stories in major publications, even a three-part Ken Burns documentary. Top researchers throw around words like "breakthrough," "revolutionary," "remission" and "cure."
I'm envious because the disease I advocate for isn't cancer: It's Alzheimer's.
My own Alzheimer's experience runs deep. I've lost grandmothers, aunts and uncles, and both of my parents to it. Unless there is a major research breakthrough, the chances are high I'll also live with and die from Alzheimer's.
Now labeled the most expensive disease in America, Alzheimer's costs our nation $226 million annually. Five million Americans live with the disease, and by 2050 that number may escalate to 16 million with the cost of care topping $1 trillion.
Unlike any of the other leading causes of death in the U.S., Alzheimer's has no cure, no effective treatments, and no way to slow its progression.
Alzheimer's is health crisis like no other. So, why haven't there been any major breakthroughs?
It all comes down to money.